NCT07110779

Brief Summary

The aim of this research is to determine whether follow-up through telehealth consultations can enhance adherence to medication and increase knowledge about heart disease in patients with coronary artery disease (CAD) who have undergone coronary angioplasty. It can include individuals of any sex or gender, aged over 18, and with access to communication devices such as a cell phone, tablet, or internet-enabled computer. The main questions to be answered are:

  • Does follow-up of patients with CAD through telenursing consultations improve adherence to the proposed treatment?
  • Does the follow-up of patients with CAD, through telenursing consultations, improve knowledge about heart disease? The researchers will compare these patients with others who will be followed up as usual at the hospital to determine which group shows better adherence to drug treatment and greater knowledge about heart disease. The participants will have telenursing consultations at three intervals: one, three, and five months after the initial consultation. After six months from the first interview, both groups will be assessed. They will also be invited to participate in an activity to share their experiences and identify research priorities in the field, with the option to collaborate on future research.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for not_applicable coronary-artery-disease

Timeline
5mo left

Started Aug 2025

Shorter than P25 for not_applicable coronary-artery-disease

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress66%
Aug 2025Oct 2026

First Submitted

Initial submission to the registry

July 21, 2025

Completed
11 days until next milestone

Study Start

First participant enrolled

August 1, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 8, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2026

Last Updated

August 8, 2025

Status Verified

June 1, 2025

Enrollment Period

11 months

First QC Date

July 21, 2025

Last Update Submit

July 31, 2025

Conditions

Keywords

coronary artery diseasecardiovascular diseasestelenursingdigital healthnursing

Outcome Measures

Primary Outcomes (2)

  • CADE-Q SV score

    The knowledge score regarding coronary artery disease (CAD) will be calculated using the Coronary Artery Disease Education Questionnaire Short Version (CADE-Q SV). This consists of 20 questions divided into five categories: clinical condition, risk factors, exercise, nutrition, and psychosocial risk. One point is awarded for each correct answer, with a maximum score of 20 points. The questionnaire aims to identify areas of low knowledge.

    From the first appointment after coronary angioplasty until six months afterwards.

  • MTA score

    Adherence to the proposed treatment will be calculated using the Measure of Treatment Adherence (MTA) instrument. This consists of seven questions, with answers obtained using a six-point Likert scale. Adherence to treatment is determined by adding the values of each answer and dividing by the total number of items. Patients with an arithmetic mean score between one and four are considered non-adherent. Those with a score between five and six are considered adherent.

    From the first appointment after coronary angioplasty until six months afterwards.

Secondary Outcomes (11)

  • Blood pressure

    At the first consultation after coronary angioplasty, and six months later.

  • Heart rate

    At the first consultation after coronary angioplasty, and six months later

  • Respiratory rate

    At the first consultation after coronary angioplasty, and six months later

  • Temperature

    At the first consultation after coronary angioplasty, and six months later

  • Capillary blood glucose

    At the first consultation after coronary angioplasty, and six months later

  • +6 more secondary outcomes

Study Arms (2)

Telenursing consultation

EXPERIMENTAL

The intervention consists of telenursing appointments held at three points in time: one, three and five months after the first appointment.

Behavioral: Telenursing consultation

Traditional follow-up

NO INTERVENTION

A final face-to-face evaluation will be conducted six months after the angioplasty to assess adherence to treatment and understanding of the coronary artery disease.

Interventions

Telenursing consultations, which will be carried out via telephone calls, video calls, or messaging platforms, will be held between one, three, and five months after the first consultation. The North American Nursing Diagnosis Association (NANDA-I), the Nursing Outcomes Classification (NOC), and the Nursing Interventions Classification (NIC) taxonomies will be used to structure these consultations.

Telenursing consultation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergoing coronary angioplasty who have access to communication devices (mobile phone, tablet or computer with internet access).

You may not qualify if:

  • Patients with serious comorbidities that prevent remote monitoring, those without access to the necessary technology for remote nursing, and those with a diagnosis that prevents communication.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculdade de Medicina de Botucatu - UNESP

Botucatu, São Paulo, 18618687, Brazil

Location

Related Publications (38)

  • Borba LO, Capistrano FC, Ferreira ACZ, Kalinke LP, Mantovani MF, Maftum MA. Adaptation and validation of the Measuring of Treatment Adherence for mental health. Rev Bras Enferm. 2018;71(suppl 5):2243-2250. doi: 10.1590/0034-7167-2017-0796. English, Portuguese.

    PMID: 30365790BACKGROUND
  • Delgado AB, Lima ML. Contributo para a validação concorrente de uma medida de adesão aos tratamentos. Psicol Saúde Doenças. 2001; 2(2):81-100. Available from: https://scielo.pt/pdf/psd/v2n2/v2n2a06.pdf

    BACKGROUND
  • Ghisi GL, Durieux A, Manfroi WC, Herdy AH, Carvalho Td, Andrade A, Benetti M. Construction and validation of the CADE-Q for patient education in cardiac rehabilitation programs. Arq Bras Cardiol. 2010 Jun;94(6):813-22. doi: 10.1590/s0066-782x2010005000045. Epub 2010 May 7. English, Portuguese.

    PMID: 20464275BACKGROUND
  • Ghisi GLM, Chaves GSS, Loures JB, Bonfim GM, Britto R. Validation of the Brazilian-Portuguese Version of a Short Questionnaire to Assess Knowledge in Cardiovascular Disease Patients (CADE-Q SV). Arq Bras Cardiol. 2018 Dec;111(6):841-849. doi: 10.5935/abc.20180169. Epub 2018 Sep 21.

    PMID: 30281691BACKGROUND
  • Nygaard A, Halvorsrud L, Linnerud S, Grov EK, Bergland A. The James Lind Alliance process approach: scoping review. BMJ Open. 2019 Aug 30;9(8):e027473. doi: 10.1136/bmjopen-2018-027473.

    PMID: 31473612BACKGROUND
  • Boutron I, Altman DG, Moher D, Schulz KF, Ravaud P; CONSORT NPT Group. CONSORT Statement for Randomized Trials of Nonpharmacologic Treatments: A 2017 Update and a CONSORT Extension for Nonpharmacologic Trial Abstracts. Ann Intern Med. 2017 Jul 4;167(1):40-47. doi: 10.7326/M17-0046. Epub 2017 Jun 20.

    PMID: 28630973BACKGROUND
  • Pereira SM, Barreto ML. Estudos de intervenção. In: Filho NA, Barreto ML. Epidemiologia & Saúde: Fundamentos, Métodos, Aplicações. 1ª ed. Rio de Janeiro: Guanabara Koogan; 2012. p. 215-24.

    BACKGROUND
  • Bensenor IM, Goulart AC, Thomas GN, Lip GYH; NIHR Global Health Research Group on Atrial Fibrillation Management. Patient and Public Involvement and Engagement (PPIE): first steps in the process of the engagement in research projects in Brazil. Braz J Med Biol Res. 2022 Jul 25;55:e12369. doi: 10.1590/1414-431X2022e12369. eCollection 2022.

    PMID: 35894383BACKGROUND
  • Oliver K, Kothari A, Mays N. The dark side of coproduction: do the costs outweigh the benefits for health research? Health Res Policy Syst. 2019 Mar 28;17(1):33. doi: 10.1186/s12961-019-0432-3.

    PMID: 30922339BACKGROUND
  • Brett J, Staniszewska S, Mockford C, Herron-Marx S, Hughes J, Tysall C, Suleman R. A systematic review of the impact of patient and public involvement on service users, researchers and communities. Patient. 2014;7(4):387-95. doi: 10.1007/s40271-014-0065-0.

    PMID: 25034612BACKGROUND
  • Modigh A, Sampaio F, Moberg L, Fredriksson M. The impact of patient and public involvement in health research versus healthcare: A scoping review of reviews. Health Policy. 2021 Sep;125(9):1208-1221. doi: 10.1016/j.healthpol.2021.07.008. Epub 2021 Jul 24.

    PMID: 34376328BACKGROUND
  • Russell J, Fudge N, Greenhalgh T. The impact of public involvement in health research: what are we measuring? Why are we measuring it? Should we stop measuring it? Res Involv Engagem. 2020 Oct 27;6:63. doi: 10.1186/s40900-020-00239-w. eCollection 2020.

    PMID: 33133636BACKGROUND
  • Gibson A, Britten N, Lynch J. Theoretical directions for an emancipatory concept of patient and public involvement. Health (London). 2012 Sep;16(5):531-47. doi: 10.1177/1363459312438563. Epub 2012 Apr 25.

    PMID: 22535648BACKGROUND
  • Hughes M, Duffy C. Public involvement in health and social sciences research: A concept analysis. Health Expect. 2018 Dec;21(6):1183-1190. doi: 10.1111/hex.12825. Epub 2018 Aug 29.

    PMID: 30159960BACKGROUND
  • Ocloo J, Garfield S, Franklin BD, Dawson S. Exploring the theory, barriers and enablers for patient and public involvement across health, social care and patient safety: a systematic review of reviews. Health Res Policy Syst. 2021 Jan 20;19(1):8. doi: 10.1186/s12961-020-00644-3.

    PMID: 33472647BACKGROUND
  • Padilha JC, Santos VB, Lopes CT, Lopes JL. Prevalence of pharmacological adherence in patients with coronary artery disease and associated factors. Rev Lat Am Enfermagem. 2021 Sep 3;29:e3464. doi: 10.1590/1518-8345.4554.3464. eCollection 2021.

    PMID: 34495187BACKGROUND
  • Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, Himmelfarb CD, Khera A, Lloyd-Jones D, McEvoy JW, Michos ED, Miedema MD, Munoz D, Smith SC Jr, Virani SS, Williams KA Sr, Yeboah J, Ziaeian B. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 Sep 10;140(11):e596-e646. doi: 10.1161/CIR.0000000000000678. Epub 2019 Mar 17. No abstract available.

    PMID: 30879355BACKGROUND
  • Saki M, Najmi S, Gholami M, Ebrahimzadeh F, Pour FJ. The effect of patient-centered education in adherence to the treatment regimen in patients with coronary artery disease. J Vasc Nurs. 2022 Mar;40(1):28-34. doi: 10.1016/j.jvn.2021.10.003. Epub 2021 Oct 27.

    PMID: 35287831BACKGROUND
  • Sefidi N, Assarroudi A, Zandi Z, Malkemes SJ, Rakhshani MH, Abbaszade A, Sahebkar M. Evaluating the effects of telenursing on patients' activities of daily living and instrumental activities of daily living after myocardial infarction: A randomized controlled trial study. Geriatr Gerontol Int. 2022 Aug;22(8):616-622. doi: 10.1111/ggi.14426. Epub 2022 Jun 22.

    PMID: 35734811BACKGROUND
  • Cunha DCPTD, Rossi LA, Dessote CAM, Bolela F, Dantas RAS. Evolution of self-care in patients with heart failure at the first outpatient return and three months after hospital discharge. Rev Lat Am Enfermagem. 2021 Jul 19;29:e3440. doi: 10.1590/1518-8345.4364.3440. eCollection 2021.

    PMID: 34287539BACKGROUND
  • Nava LF, Duarte TTP, Lima WL, Magro MCS. Monitoramento avançado de enfermagem: pacientes de risco na atenção primária. Esc Anna Nery 2022; 26: e20210282. DOI: https://doi.org/10.1590/2177-9465-EAN-2021-0282

    BACKGROUND
  • Abraham C, Jensen C, Rossiter L, Dittman Hale D. Telenursing and Remote Patient Monitoring in Cardiovascular Health. Telemed J E Health. 2024 Mar;30(3):771-779. doi: 10.1089/tmj.2023.0187. Epub 2023 Sep 8.

    PMID: 37682280BACKGROUND
  • Nurmeksela A, Pihlainen V, Kettunen T, Laukkanen J, Peltokoski J. Nurse-led counseling for coronary artery disease patients: A 1-year follow-up study. Nurs Health Sci. 2021 Sep;23(3):678-687. doi: 10.1111/nhs.12852. Epub 2021 Jun 3.

    PMID: 33991019BACKGROUND
  • Sousa VLP, Dourado Junior FW, Anjos SJSBD, Moreira ACA. Nursing teleconsultation in primary health care: scoping review. Rev Lat Am Enfermagem. 2024 Sep 2;32:e4329. doi: 10.1590/1518-8345.7212.4329. eCollection 2024.

    PMID: 39230178BACKGROUND
  • Iyamu I, Xu AXT, Gomez-Ramirez O, Ablona A, Chang HJ, Mckee G, Gilbert M. Defining Digital Public Health and the Role of Digitization, Digitalization, and Digital Transformation: Scoping Review. JMIR Public Health Surveill. 2021 Nov 26;7(11):e30399. doi: 10.2196/30399.

    PMID: 34842555BACKGROUND
  • Fatehi F, Samadbeik M, Kazemi A. What is Digital Health? Review of Definitions. Stud Health Technol Inform. 2020 Nov 23;275:67-71. doi: 10.3233/SHTI200696.

    PMID: 33227742BACKGROUND
  • Lapão LV. A Enfermagem do Futuro: combinando Saúde Digital e a Liderança do Enfermeiro. Rev. Latino-Am. Enfermagem. 2020; 28:e3338. DOI: http://dx.doi.org/10.1590/1518-8345.0000-3338

    BACKGROUND
  • Sousa SM, Bernardino E, Peres AM, Martins MM, Goncalves LS, Lacerda MR. The role of nurses in the integration of care for people with chronic noncommunicable diseases. Rev Esc Enferm USP. 2021 Sep 6;55:e20200131. doi: 10.1590/1980-220X-REEUSP-2020-0131. eCollection 2021. English, Portuguese.

    PMID: 34495207BACKGROUND
  • Marcon SS, Ganassin GS, Arruda GO, Téston EF, Barreto MS, Marquete VF, Ferreira PC. Intervenção educativa no local de trabalho: promoção da saúde e prevenção cardiovascular com homens metalúrgicos. Rev. Baiana Enferm. 2021; 35: e 38619. DOI: https://doi.org/10.18471/rbe.v35.38619

    BACKGROUND
  • Arruda GO, Marcon SS, Peruzzo HE, Ruiz AGB, Back IR, Nass EMA, et al. Intervenção educativa em homens com diabetes mellitus: efeitos sobre comportamentos e perfil antropométrico. Acta Paul Enferm. 2020; 33: eAPE20190128. DOI: https://doi.org/10.37689/acta-ape/2020AO0128

    BACKGROUND
  • Arruda JA, Lemke VG, Mariani Jr. J, Barbosa AHP, Quadros AS, Pedra C et al. Posicionamento da Sociedade Brasileira de Cardiologia e da Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista sobre Centro de Treinamento e Certificação Profissional em Hemodinâmica e Cardiologia Intervencionista - 2020. Arq Bras Cardiol. 2020; 114(1):137-93. DOI: https://doi.org/10.36660/abc.2019084

    BACKGROUND
  • Correction to: 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 Sep 10;140(11):e649-e650. doi: 10.1161/CIR.0000000000000725. Epub 2019 Sep 9. No abstract available.

    PMID: 31498691BACKGROUND
  • O'Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H, Rao-Melacini P, Zhang X, Pais P, Agapay S, Lopez-Jaramillo P, Damasceno A, Langhorne P, McQueen MJ, Rosengren A, Dehghan M, Hankey GJ, Dans AL, Elsayed A, Avezum A, Mondo C, Diener HC, Ryglewicz D, Czlonkowska A, Pogosova N, Weimar C, Iqbal R, Diaz R, Yusoff K, Yusufali A, Oguz A, Wang X, Penaherrera E, Lanas F, Ogah OS, Ogunniyi A, Iversen HK, Malaga G, Rumboldt Z, Oveisgharan S, Al Hussain F, Magazi D, Nilanont Y, Ferguson J, Pare G, Yusuf S; INTERSTROKE investigators. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet. 2016 Aug 20;388(10046):761-75. doi: 10.1016/S0140-6736(16)30506-2. Epub 2016 Jul 16.

    PMID: 27431356BACKGROUND
  • Lanas F, Avezum A, Bautista LE, Diaz R, Luna M, Islam S, Yusuf S; INTERHEART Investigators in Latin America. Risk factors for acute myocardial infarction in Latin America: the INTERHEART Latin American study. Circulation. 2007 Mar 6;115(9):1067-74. doi: 10.1161/CIRCULATIONAHA.106.633552.

    PMID: 17339564BACKGROUND
  • Teo KK, Rafiq T. Cardiovascular Risk Factors and Prevention: A Perspective From Developing Countries. Can J Cardiol. 2021 May;37(5):733-743. doi: 10.1016/j.cjca.2021.02.009. Epub 2021 Feb 19.

    PMID: 33610690BACKGROUND
  • Feliciano SCDC, Villela PB, Oliveira GMM. Association between Mortality from Chronic Noncommunicable Diseases and Human Development Index in Brazil between 1980 and 2019. Arq Bras Cardiol. 2023 Apr 21;120(4):e20211009. doi: 10.36660/abc.20211009. eCollection 2023. English, Portuguese.

    PMID: 37098983BACKGROUND
  • Mansur AP, Favarato D. Cardiovascular and Cancer Death Rates in the Brazilian Population Aged 35 to 74 Years, 1996-2017. Arq Bras Cardiol. 2021 Aug;117(2):329-340. doi: 10.36660/abc.20200233. English, Portuguese.

    PMID: 34495229BACKGROUND
  • Tsao CW, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, Baker-Smith CM, Beaton AZ, Boehme AK, Buxton AE, Commodore-Mensah Y, Elkind MSV, Evenson KR, Eze-Nliam C, Fugar S, Generoso G, Heard DG, Hiremath S, Ho JE, Kalani R, Kazi DS, Ko D, Levine DA, Liu J, Ma J, Magnani JW, Michos ED, Mussolino ME, Navaneethan SD, Parikh NI, Poudel R, Rezk-Hanna M, Roth GA, Shah NS, St-Onge MP, Thacker EL, Virani SS, Voeks JH, Wang NY, Wong ND, Wong SS, Yaffe K, Martin SS; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association. Circulation. 2023 Feb 21;147(8):e93-e621. doi: 10.1161/CIR.0000000000001123. Epub 2023 Jan 25.

    PMID: 36695182BACKGROUND

Related Links

MeSH Terms

Conditions

Coronary Artery DiseaseCardiovascular Diseases

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Study Officials

  • Fernanda MA Lima, PhD

    Universidade Estadual Paulista "Júlio de Mesquita Filho" - Unesp

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Fernanda MA Lima, PhD

CONTACT

Marla AG Avila, Professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Collaborating professor

Study Record Dates

First Submitted

July 21, 2025

First Posted

August 8, 2025

Study Start

August 1, 2025

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

October 1, 2026

Last Updated

August 8, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will share

The data will be preserved in accordance with the institution's repository policy and will be made available in the open access repository itself and presented at scientific conferences in the field, as well as publications in journals, keeping sensitive data anonymous.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
August 2025 - October 2026
Access Criteria
Access to research data by external parties will only be authorized upon prior request to the project's managing researcher. Data linked to manuscripts submitted or in the process of being submitted will be shared after acceptance and publication.

Locations